Safety and efficacy of feed additives consisting of Vitamin B2 (98%) and Vitamin B2 (80%) as riboflavin produced by Bacillus subtilis KCCM 10445 for all animal species (Hubei Guangji Pharmaceutical Co. Ltd.)
Open Access
- 1 June 2021
- journal article
- research article
- Published by Wiley in EFSA Journal
- Vol. 19 (6), e06629
- https://doi.org/10.2903/j.efsa.2021.6629
Abstract
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of vitamin B-2 98% and vitamin B-2 80% in the form of riboflavin produced by fermentation with a genetically modified strain of Bacillus subtilis (KCCM 10445) as nutritional additives in feed and water for drinking for all animal species. The production strain harbours antimicrobial resistance genes. With the data available the Panel is not in the position to confirm the correspondence between the strain deposited under accession number KCCM 10445 and the strain under the current assessment. The production strain and its recombinant DNA were not detected in the final products. Therefore, the additives do not pose any safety concern associated with the genetic modification of the production strain. The additives are safe for the target species, the consumer and the environment. Vitamin B-2 80% is not hazardous by inhalation. In the absence of data, no conclusions on the possible risk by inhalation of vitamin B-2 98% can be reached. Neither vitamin B2 98% nor vitamin B-2 80% are irritant to skin or eyes. In the absence of data, no conclusions on the skin sensitisation potential of the additives can be reached. The additives under assessment are effective in covering the animals' requirements for vitamin B-2 when administered via feed and/or water for drinking. (c) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.This publication has 17 references indexed in Scilit:
- Safety of vitamin B2 (80%) as riboflavin produced by Bacillus subtilis KCCM‐10445 for all animal speciesEFSA Journal, 2018
- Guidance on the assessment of the safety of feed additives for the consumerEFSA Journal, 2017
- Guidance on the identity, characterisation and conditions of use of feed additivesEFSA Journal, 2017
- Guidance on the assessment of the safety of feed additives for the target speciesEFSA Journal, 2017
- Safety and efficacy of vitamin B2 (riboflavin and riboflavin 5’‐phosphate ester monosodium salt) produced by Bacillus subtilis for all animal species based on a dossier submitted by DSMEFSA Journal, 2016
- Scientific Opinion on the safety and efficacy of vitamin B2 (80 %) as riboflavin produced by Bacillus subtilis for all animal species, based on a dossier submitted by VITAC EEIGEFSA Journal, 2014
- Scientific Opinion on the re‐evaluation of riboflavin (E 101(i)) and riboflavin‐5′‐phosphate sodium (E 101(ii)) as food additivesEFSA Journal, 2013
- Guidance on studies concerning the safety of use of the additive for users/workersEFSA Journal, 2012
- Mutations in therpsLGene Are Involved in Streptomycin Resistance inCampylobacter coliMicrobial Drug Resistance, 2010
- Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA - Opinion of the Scientific CommitteeEFSA Journal, 2007